Generali Asset Management SPA SGR Acquires Shares of 4,199 STERIS plc (NYSE:STE)

Generali Asset Management SPA SGR bought a new position in STERIS plc (NYSE:STEFree Report) in the 4th quarter, HoldingsChannel.com reports. The institutional investor bought 4,199 shares of the medical equipment provider’s stock, valued at approximately $863,000.

A number of other large investors have also recently modified their holdings of STE. Avalon Trust Co purchased a new stake in STERIS in the fourth quarter worth about $30,000. Human Investing LLC purchased a new position in shares of STERIS in the 4th quarter valued at approximately $31,000. Anfield Capital Management LLC boosted its position in shares of STERIS by 100.0% during the fourth quarter. Anfield Capital Management LLC now owns 182 shares of the medical equipment provider’s stock valued at $37,000 after purchasing an additional 91 shares in the last quarter. Central Pacific Bank Trust Division grew its stake in STERIS by 65.5% in the fourth quarter. Central Pacific Bank Trust Division now owns 192 shares of the medical equipment provider’s stock worth $39,000 after purchasing an additional 76 shares during the period. Finally, Manchester Capital Management LLC raised its holdings in STERIS by 182.7% in the fourth quarter. Manchester Capital Management LLC now owns 212 shares of the medical equipment provider’s stock worth $44,000 after purchasing an additional 137 shares in the last quarter. Institutional investors own 94.69% of the company’s stock.

STERIS Price Performance

Shares of STERIS stock opened at $225.48 on Friday. The stock’s fifty day moving average is $220.73 and its 200 day moving average is $222.27. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.40 and a current ratio of 2.13. STERIS plc has a one year low of $197.82 and a one year high of $248.24. The stock has a market cap of $22.15 billion, a P/E ratio of 47.87 and a beta of 0.92.

STERIS (NYSE:STEGet Free Report) last released its earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share for the quarter, missing analysts’ consensus estimates of $2.33 by ($0.01). STERIS had a net margin of 8.66% and a return on equity of 13.91%. Sell-side analysts anticipate that STERIS plc will post 9.08 earnings per share for the current year.

STERIS Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, March 21st. Shareholders of record on Thursday, February 20th will be issued a dividend of $0.57 per share. This represents a $2.28 dividend on an annualized basis and a yield of 1.01%. The ex-dividend date of this dividend is Thursday, February 20th. STERIS’s dividend payout ratio (DPR) is currently 48.41%.

Analysts Set New Price Targets

A number of analysts have recently weighed in on the stock. Piper Sandler upped their target price on shares of STERIS from $260.00 to $265.00 and gave the stock an “overweight” rating in a research report on Monday, February 3rd. JMP Securities reaffirmed a “market outperform” rating and issued a $265.00 price objective on shares of STERIS in a research report on Thursday, February 6th. Finally, Stephens reaffirmed an “overweight” rating and set a $240.00 price target on shares of STERIS in a report on Thursday, February 6th. One investment analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. According to data from MarketBeat, STERIS presently has a consensus rating of “Moderate Buy” and a consensus target price of $258.75.

Check Out Our Latest Stock Report on STERIS

About STERIS

(Free Report)

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.

See Also

Want to see what other hedge funds are holding STE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for STERIS plc (NYSE:STEFree Report).

Institutional Ownership by Quarter for STERIS (NYSE:STE)

Receive News & Ratings for STERIS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS and related companies with MarketBeat.com's FREE daily email newsletter.